Tesamorelin
Tesamorelin is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH) consisting of the full 44-amino acid GHRH sequence with a trans-3-hexenoic acid modification. It is FDA-approved (as Egrifta) for the reduction of excess abdominal fat in HIV patients and is widely studied for metabolic and cognitive benefits.
Choose your dosage
Purity: 99%
Form: Lyophilized Powder
Description
DEFINITION
Tesamorelin is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH) consisting of the full 44-amino acid GHRH sequence with a trans-3-hexenoic acid modification. It is FDA-approved (as Egrifta) for the reduction of excess abdominal fat in HIV patients and is widely studied for metabolic and cognitive benefits.
KEY BENEFITS
■FDA-approved for visceral adiposity reduction — especially abdominal fat
â– Increases IGF-1 and GH levels with physiological pulsatility
â– Improves lipid profiles and reduces cardiovascular risk markers
■Supports cognitive function — studies show improvement in mild cognitive impairment
â– Better tolerability profile compared to exogenous HGH
Available Quantities
10mg
All products are sold for research and laboratory use only.
